Concepedia

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

A. Herbaut, Franck Fajnkuchen, L. Qu-Knafo, Sylvia Nghiem‐Buffet, Bahram Bodaghi, Audrey Giocanti‐Auregan

Journal of Ophthalmology · 2017 · 21 citations · 14 references

DOIFull text

Open access

Abstract

Switching to aflibercept in refractory DME results in significant functional and anatomical improvement. The study was approved by the France Macula Federation ethical committee (FMF 2017-138).

References

14

Ranibizumab for Diabetic Macular Edema

Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology · 2012 · 1.6K citations

, , +4

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

David S. Boyer, Young Hee Yoon, Rubens Belfort et al. · Ophthalmology · 2014 · 1.1K citations · Full text

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

Nicholas Papadopoulos, Joel Martin, Qin Ruan et al. · Angiogenesis · 2012 · 1K citations · Full text

, , +11

Intravitreal Aflibercept for Diabetic Macular Edema

Jean‐François Korobelnik, V. Diana, Ursula Schmidt‐Erfurth et al. · Ophthalmology · 2014 · 785 citations · Full text

, , +2

Intravitreal Aflibercept for Diabetic Macular Edema

David M. Brown, Ursula Schmidt‐Erfurth, V. Diana et al. · Ophthalmology · 2015 · 602 citations

, , +2